share_log
Breakings ·  Jun 21 07:30
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85TH Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, Accg-2671
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment